ClinicalTrials.govpublic full text
Multiple Ascending Dose Phase I Study in Order to Define Lanifibranor (IVA337) Supra-thjerapeutic Dose
healthy subjects, healthy male volunteers, multiple ascending dose, supra-therapeutic dose, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 803390
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.